


Paromax CR 12.5mg Tablets – Paroxetine Controlled Release (Rx)
Pay in 3 Installments of
Rs.
425
Description
Paromax CR 12.5mg Tablets — Paroxetine Controlled-Release SSRI (Rx)
Paromax CR 12.5mg Tablets contain Paroxetine Hydrochloride in a controlled-release (CR) formulation. Unlike immediate-release Paroxetine, the CR form uses a geomatrix delivery system to gradually release the drug over the day, reducing peak plasma concentration fluctuations. This results in fewer gastrointestinal side effects (nausea, diarrhoea) and is often better tolerated at treatment initiation — particularly important for patients who previously experienced GI intolerance with immediate-release Paroxetine.
Paromax CR 12.5mg carries the same clinical indications as immediate-release Paroxetine:
- Major Depressive Disorder (MDD)
- Panic Disorder (with or without agoraphobia)
- Obsessive-Compulsive Disorder (OCD)
- Social Anxiety Disorder (SAD)
- Post-Traumatic Stress Disorder (PTSD)
- Generalised Anxiety Disorder (GAD)
Critical clinical notes — same as all Paroxetine formulations:
- Strongest CYP2D6 inhibitor among SSRIs — important drug–drug interactions; always review co-medications with prescribing doctor
- Most severe SSRI discontinuation syndrome (short half-life ~21h). The CR formulation does NOT eliminate discontinuation risk — gradual tapering under medical supervision is mandatory
- Anticholinergic side effects (dry mouth, constipation, urinary retention) possible
- Weight gain with long-term use
- Teratogenic risk in late pregnancy — discuss with doctor
Prescription-only medicine. Share your prescription at sales@derma.pk or WhatsApp 0320-5999650.
Key Clinical Points
- Controlled-release formula — fewer GI side effects vs. immediate-release Paroxetine
- Same broad indications: MDD, OCD, panic disorder, PTSD, GAD, social anxiety
- Strongest CYP2D6 inhibitor among SSRIs — drug interactions must be reviewed
- Discontinuation syndrome risk remains despite CR formulation — never stop abruptly
- Psychiatric/medical supervision required; 12.5mg is a low starting or maintenance dose
Prescription Required
Paromax CR 12.5mg is prescription-only. Do not self-medicate or stop without medical guidance. Send prescription to sales@derma.pk or WhatsApp 0320-5999650. Delivery to Lahore, Karachi, Islamabad and all Pakistan.
See our full antidepressants collection and all prescription medicines at Derma.pk.
Usage & Benefits
- Controlled-release formula — reduced GI side effects vs. immediate-release Paroxetine
- Same broad indications: MDD, OCD, panic disorder, PTSD, GAD, social anxiety
- Gradual drug release improves tolerability at treatment initiation
- 12.5mg low starting dose suitable for treatment initiation or sensitive patients
- Consistent daily drug exposure supports sustained antidepressant effect
How To Use
Take exactly as prescribed — typically once daily in the morning with food. Swallow whole; do not crush or chew (CR formulation). Do not stop without medical advice; gradual tapering is mandatory. The CR formulation does not eliminate discontinuation syndrome risk — Paroxetine still has the shortest SSRI half-life. Review all co-medications with your doctor (CYP2D6 inhibitor).
FAQs
What is the advantage of Paromax CR over regular Paromax tablets?
The controlled-release (CR) formulation delivers Paroxetine more gradually, reducing peak plasma levels. This results in fewer gastrointestinal side effects, particularly nausea at treatment initiation.
Does the CR formulation eliminate discontinuation syndrome?
No. Despite the controlled release, Paroxetine's short half-life (~21 hours) still makes discontinuation syndrome a risk. Never stop Paromax CR abruptly — always taper gradually under medical supervision.
What is the 12.5mg dose used for?
Paromax CR 12.5mg is often used as a starting dose in treatment-naive patients, elderly patients, or those requiring gentle titration, before moving to higher doses.
Is a prescription required for Paromax CR 12.5mg?
Yes — prescription-only. Send your valid Rx to sales@derma.pk or WhatsApp 0320-5999650.
